Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A high index level often signals stronger market momentum or potential overbought conditions. Grasp its implications to adjust exposure and risk.
25,713 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Boeing’s June performance marks more than a monthly milestone. With 64 jets delivered, the company nudges its cash fl...
Choosing the right investing platform can save time and money. This guide shows how to pick tools that align with you...
A reserves-and-resources update put Coeur Mining back in focus, with millions of ounces of gold on the books and a pr...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...
The Fed's May inflation outlook caught investors off guard and sparked a rethink of risk, rates, and returns. This gu...
Bloom Energy stock reached a fresh intraday high as data-center demand and green-energy tech advances grab headlines....
When markets tumble, some dividend stocks stand out as thoughtful buys. This article explains how to spot a truly res...
A crypto once riding high can crash hard. This guide lays out a practical plan to decide if you should hold, trim, or...
Inflation has squeezed most Americans, but American Express remains focused on the affluent. This article examines wh...
Weekend reads aren’t just for leisure—they’re a powerful way to sharpen investing judgment. This guide blends long-fo...
U.S. savers are seeing a wave of HYSA promotions with big headline yields that may fade after a short window. This pi...